| Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non–small-cell lung cancer IS Grills, VS Mangona, R Welsh, G Chmielewski, E McInerney, S Martin, ... Journal of clinical oncology 28 (6), 928-935, 2010 | 510 | 2010 |
| Tumor volume as a predictor of survival and local control in patients with brain metastases treated with Gamma Knife surgery AM Baschnagel, KD Meyer, PY Chen, DJ Krauss, RE Olson, DR Pieper, ... Journal of neurosurgery 119 (5), 1139-1144, 2013 | 194 | 2013 |
| Dose escalation improves cancer-related events at 10 years for intermediate-and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and … AA Martinez, J Gonzalez, H Ye, M Ghilezan, S Shetty, K Kernen, ... International Journal of Radiation Oncology* Biology* Physics 79 (2), 363-370, 2011 | 194 | 2011 |
| Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or … T Swanson, IS Grills, H Ye, A Entwistle, M Teahan, N Letts, D Yan, ... American journal of clinical oncology 36 (1), 24-30, 2013 | 182 | 2013 |
| Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer N Mohammed, L Kestin, M Ghilezan, D Krauss, F Vicini, D Brabbins, ... International Journal of Radiation Oncology* Biology* Physics 82 (1), 204-212, 2012 | 173 | 2012 |
| Surgical resection of brain metastases and the risk of leptomeningeal recurrence in patients treated with stereotactic radiosurgery MD Johnson, V Avkshtol, AM Baschnagel, K Meyer, H Ye, IS Grills, ... International Journal of Radiation Oncology* Biology* Physics 94 (3), 537-543, 2016 | 131 | 2016 |
| Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer C Shah, TB Lanni Jr, MI Ghilezan, GS Gustafson, KS Marvin, H Ye, ... Brachytherapy 11 (6), 441-445, 2012 | 114 | 2012 |
| High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data M Ghilezan, A Martinez, G Gustason, D Krauss, JV Antonucci, P Chen, ... International Journal of Radiation Oncology* Biology* Physics 83 (3), 927-932, 2012 | 103 | 2012 |
| Outcomes associated with 3 treatment schedules of high-dose-rate brachytherapy monotherapy for favorable-risk prostate cancer MS Jawad, JT Dilworth, GS Gustafson, H Ye, M Wallace, A Martinez, ... International Journal of Radiation Oncology* Biology* Physics 94 (4), 657-666, 2016 | 92 | 2016 |
| Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer J Huang, LL Kestin, H Ye, M Wallace, AA Martinez, FA Vicini Radiotherapy and Oncology 98 (1), 81-86, 2011 | 89 | 2011 |
| Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate-and high-risk prostate cancer D Krauss, L Kestin, H Ye, D Brabbins, M Ghilezan, G Gustafson, F Vicini, ... International Journal of Radiation Oncology* Biology* Physics 80 (4), 1064-1071, 2011 | 88 | 2011 |
| Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation F Vicini, D Arthur, D Wazer, P Chen, C Mitchell, M Wallace, L Kestin, H Ye International Journal of Radiation Oncology* Biology* Physics 79 (4), 977-984, 2011 | 79 | 2011 |
| Intrafraction variation of mean tumor position during image-guided hypofractionated stereotactic body radiotherapy for lung cancer C Shah, IS Grills, LL Kestin, S McGrath, H Ye, SK Martin, D Yan International Journal of Radiation Oncology* Biology* Physics 82 (5), 1636-1641, 2012 | 78 | 2012 |
| Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical … SS Park, D Yan, S McGrath, JT Dilworth, J Liang, H Ye, DJ Krauss, ... International Journal of Radiation Oncology* Biology* Physics 83 (3), 947-952, 2012 | 76 | 2012 |
| Percentage of positive biopsy cores: a better risk stratification model for prostate cancer? J Huang, FA Vicini, SG Williams, H Ye, S McGrath, M Ghilezan, D Krauss, ... International Journal of Radiation Oncology* Biology* Physics 83 (4), 1141-1148, 2012 | 72 | 2012 |
| Five-year outcomes of a single-institution prospective trial of 19-Gy single-fraction high-dose-rate brachytherapy for low-and intermediate-risk prostate cancer ZA Siddiqui, GS Gustafson, H Ye, AA Martinez, B Mitchell, E Sebastian, ... International Journal of Radiation Oncology* Biology* Physics 104 (5), 1038-1044, 2019 | 71 | 2019 |
| Dose–volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma J Huang, JM Robertson, H Ye, J Margolis, L Nadeau, D Yan International Journal of Radiation Oncology* Biology* Physics 83 (4), 1120-1125, 2012 | 66 | 2012 |
| Favorable preliminary outcomes for men with low-and intermediate-risk prostate cancer treated with 19-Gy single-fraction high-dose-rate brachytherapy DJ Krauss, H Ye, AA Martinez, B Mitchell, E Sebastian, A Limbacher, ... International Journal of Radiation Oncology* Biology* Physics 97 (1), 98-106, 2017 | 64 | 2017 |
| Relationship between construction characteristics and carbon emissions from urban household operational energy usage H Ye, K Wang, X Zhao, F Chen, X Li, L Pan Energy and Buildings 43 (1), 147-152, 2011 | 59 | 2011 |
| Recent advances in adsorbents for the removal of phthalate esters from water: Material, modification, and application H Ye, B Zhao, Y Zhou, J Du, M Huang Chemical Engineering Journal 409, 128127, 2021 | 50 | 2021 |
Michelle F. Wallace, RN, BSN, OCN, C...Radiation Oncology Nurse Clinician, Beaumont Cancer Institute, Beaumont Health Systems在 beaumont.edu 的电子邮件经过验证
